We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDLI
3576
DELISTED
PDL BioPharma, Inc.
PDLI
$1K ﹤0.01%
300
-32
-10% -$104
KIQ
3577
DELISTED
Kelso Technologies Inc.
KIQ
$1K ﹤0.01%
900
MTL
3578
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$1K ﹤0.01%
496
+437
+741% +$890
ALACU
3579
DELISTED
Alberton Acquisition Corp Unit
ALACU
$1K ﹤0.01%
+78
New +$802
IHC
3580
DELISTED
Independence Holding Company
IHC
$1K ﹤0.01%
15
-937
-98% -$34.8K
NYV
3581
DELISTED
Nuveen New York Municipal Value Fund 2
NYV
$1K ﹤0.01%
+100
New +$1.44K
LJPC
3582
DELISTED
La Jolla Pharmaceutical Company
LJPC
$1K ﹤0.01%
66
-4,508
-99% -$34K
LBTYB
3583
DELISTED
Liberty Global plc Class B
LBTYB
$1K ﹤0.01%
+39
New +$1.03K
AAME icon
3584
Atlantic American Corp
AAME
$31.2M
$0 ﹤0.01%
136
+120
+750% +$294
AAT
3585
American Assets Trust
AAT
$1.4B
-2,592
Closed -$119K
ACAD icon
3586
Acadia Pharmaceuticals
ACAD
$5.03B
$0 ﹤0.01%
+3
New +$77
ACET icon
3587
Adicet Bio
ACET
$74.7M
-61
Closed -$46K
ACIU icon
3588
AC Immune
ACIU
$240M
-8,164
Closed -$41K
ACLS icon
3589
Axcelis
ACLS
$4.31B
-4,935
Closed -$99K
ACN icon
3590
Accenture
ACN
$108B
-7,998
Closed -$1.41M
ACNB icon
3591
ACNB Corp
ACNB
$655M
-766
Closed -$28K
ACRS icon
3592
Aclaris Therapeutics
ACRS
$825M
-946
Closed -$6K
ADAP
3593
DELISTED
Adaptimmune Therapeutics
ADAP
$0 ﹤0.01%
100
-6,290
-98% -$25.6K
ADEA icon
3594
Adeia
ADEA
$3.11B
-9,726
Closed -$60K
ADTN icon
3595
Adtran
ADTN
$616M
-684
Closed -$9K
ADVM
3596
DELISTED
Adverum Biotechnologies
ADVM
-175
Closed -$9K
AEHL icon
3597
Antelope Enterprise Holdings
AEHL
$5.51M
0
AFBI
3598
DELISTED
Affinity Bancshares
AFBI
-88
Closed -$1K
AFL icon
3599
Aflac
AFL
$63.4B
-14,039
Closed -$702K
AG icon
3600
First Majestic Silver
AG
$9.07B
$0 ﹤0.01%
62
-24,618
-100% -$156K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.